163 related articles for article (PubMed ID: 17391064)
1. Enzymatic properties of human kallikrein-related peptidase 12 (KLK12).
Memari N; Jiang W; Diamandis EP; Luo LY
Biol Chem; 2007 Apr; 388(4):427-35. PubMed ID: 17391064
[TBL] [Abstract][Full Text] [Related]
2. Human kallikrein-related peptidase 12: antibody generation and immunohistochemical localization in prostatic tissues.
Memari N; Diamandis EP; Earle T; Campbell A; Van Dekken H; Van der Kwast TH
Prostate; 2007 Sep; 67(13):1465-74. PubMed ID: 17654496
[TBL] [Abstract][Full Text] [Related]
3. KLK12 is a novel serine protease and a new member of the human kallikrein gene family-differential expression in breast cancer.
Yousef GM; Magklara A; Diamandis EP
Genomics; 2000 Nov; 69(3):331-41. PubMed ID: 11056051
[TBL] [Abstract][Full Text] [Related]
4. Splice-site genetic polymorphism of the human kallikrein 12 (KLK12) gene correlates with no substantial expression of KLK12 protein having serine protease activity.
Shinmura K; Tao H; Yamada H; Kataoka H; Sanjar R; Wang J; Yoshimura K; Sugimura H
Hum Mutat; 2004 Sep; 24(3):273-4. PubMed ID: 15300858
[TBL] [Abstract][Full Text] [Related]
5. Crystal structures of human tissue kallikrein 4: activity modulation by a specific zinc binding site.
Debela M; Magdolen V; Grimminger V; Sommerhoff C; Messerschmidt A; Huber R; Friedrich R; Bode W; Goettig P
J Mol Biol; 2006 Oct; 362(5):1094-107. PubMed ID: 16950394
[TBL] [Abstract][Full Text] [Related]
6. Human kallikrein 4: enzymatic activity, inhibition, and degradation of extracellular matrix proteins.
Obiezu CV; Michael IP; Levesque MA; Diamandis EP
Biol Chem; 2006 Jun; 387(6):749-59. PubMed ID: 16800736
[TBL] [Abstract][Full Text] [Related]
7. Enzymatic profiling of human kallikrein 14 using phage-display substrate technology.
Felber LM; Borgoño CA; Cloutier SM; Kündig C; Kishi T; Ribeiro Chagas J; Jichlinski P; Gygi CM; Leisinger HJ; Diamandis EP; Deperthes D
Biol Chem; 2005 Mar; 386(3):291-8. PubMed ID: 15843175
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of kallikrein-related peptidases by the serine protease inhibitor of Kazal-type 6.
Kantyka T; Fischer J; Wu Z; Declercq W; Reiss K; Schröder JM; Meyer-Hoffert U
Peptides; 2011 Jun; 32(6):1187-92. PubMed ID: 21439340
[TBL] [Abstract][Full Text] [Related]
9. Biochemical characterization of human kallikrein 8 and its possible involvement in the degradation of extracellular matrix proteins.
Rajapakse S; Ogiwara K; Takano N; Moriyama A; Takahashi T
FEBS Lett; 2005 Dec; 579(30):6879-84. PubMed ID: 16337200
[TBL] [Abstract][Full Text] [Related]
10. Activation and enzymatic characterization of recombinant human kallikrein 8.
Kishi T; Cloutier SM; Kündig C; Deperthes D; Diamandis EP
Biol Chem; 2006 Jun; 387(6):723-31. PubMed ID: 16800733
[TBL] [Abstract][Full Text] [Related]
11. Human kallikrein 6 activity is regulated via an autoproteolytic mechanism of activation/inactivation.
Bayés A; Tsetsenis T; Ventura S; Vendrell J; Aviles FX; Sotiropoulou G
Biol Chem; 2004 Jun; 385(6):517-24. PubMed ID: 15255184
[TBL] [Abstract][Full Text] [Related]
12. Human tissue kallikreins: a new enzymatic cascade pathway?
Yousef GM; Diamandis EP
Biol Chem; 2002; 383(7-8):1045-57. PubMed ID: 12437087
[TBL] [Abstract][Full Text] [Related]
13. Characterization of mouse glandular kallikrein 24 expressed in testicular Leydig cells.
Matsui H; Takano N; Takahashi T
Int J Biochem Cell Biol; 2005 Nov; 37(11):2333-43. PubMed ID: 15985384
[TBL] [Abstract][Full Text] [Related]
14. Substrate-guided design of a potent and selective kallikrein-related peptidase inhibitor for kallikrein 4.
Swedberg JE; Nigon LV; Reid JC; de Veer SJ; Walpole CM; Stephens CR; Walsh TP; Takayama TK; Hooper JD; Clements JA; Buckle AM; Harris JM
Chem Biol; 2009 Jun; 16(6):633-43. PubMed ID: 19549601
[TBL] [Abstract][Full Text] [Related]
15. A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma.
Planque C; Li L; Zheng Y; Soosaipillai A; Reckamp K; Chia D; Diamandis EP; Goodglick L
Clin Cancer Res; 2008 Mar; 14(5):1355-62. PubMed ID: 18316555
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of human kallikrein 11, a candidate prostate and ovarian cancer biomarker, from seminal plasma.
Luo LY; Shan SJ; Elliott MB; Soosaipillai A; Diamandis EP
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):742-50. PubMed ID: 16467084
[TBL] [Abstract][Full Text] [Related]
17. Pro-angiogenic effect of human kallikrein-related peptidase 12 (KLK12) in lung endothelial cells does not depend on kinin-mediated activation of B2 receptor.
Kryza T; Lalmanach G; Lavergne M; Lecaille F; Reverdiau P; Courty Y; Heuzé-Vourc'h N
Biol Chem; 2013 Mar; 394(3):385-91. PubMed ID: 23152405
[TBL] [Abstract][Full Text] [Related]
18. Human kallikrein 13 involvement in extracellular matrix degradation.
Kapadia C; Ghosh MC; Grass L; Diamandis EP
Biochem Biophys Res Commun; 2004 Oct; 323(3):1084-90. PubMed ID: 15381110
[TBL] [Abstract][Full Text] [Related]
19. Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries.
Matsumura M; Bhatt AS; Andress D; Clegg N; Takayama TK; Craik CS; Nelson PS
Prostate; 2005 Jan; 62(1):1-13. PubMed ID: 15389820
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of salivary kallikrein from an insectivore (Scalopus aquaticus): substrate specificities, immunoreactivity, and kinetic analyses.
Richards GP; Zintz C; Chao J; Chao L
Arch Biochem Biophys; 1996 May; 329(1):104-12. PubMed ID: 8619626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
